Skip to main content
. Author manuscript; available in PMC: 2017 Feb 13.
Published in final edited form as: Proteomics. 2015 Jan 16;15(4):824–835. doi: 10.1002/pmic.201400243

Table 1.

Identification and quantification of MS peaks in EV from PC9 or PC9R cells in positive ion mode.

m/z pa) Ratiob) Assignment
Overexpressed in extracellular vesicles of PC9R cell
754.5 2.00 × 10−1 1.03 PC {34:4} [M+H]+
720.6 5.23 × 10−3 1.05 PC{O-32:0}[M+H]+
706.6 1.72 × 10−13 1.2 PC {30:0} [M+H]+
756.5 1.64 × 10−10 1.22 PC {34:3} [M+H]+
742.5 1.24 × 10−15 1.36 PC {O-34:3} [M+H]+/PC {P-34:2} [M+H]+
750.6 3.40 × 10−21 1.41 PC {34:6} [M+H]+
834.7 4.97 × 10−20 1.45 PC {40:6} [M+H]+
692.6 2.14 × 10−31 1.56 PC{O-30:0}[M+H]+
804.6 2.05 × 10−19 1.61 PC {38:7} [M+H]+
722.5 1.50 × 10−32 1.69 PC {30:3} [M+Na]+
550.5 1.84 × 10−20 2.39 LPC {20:1} [M+H]+
806.7 1.16 × 10−37 2.4 PC {36:3} [M+Na]+/PC {38:6} [M+H]+
770.6 6.76 × 10−49 6.06 PC {O-36:3} [M+H]+/PC {P-36:2} [M+H]+
912.7 7.03 × 10−35 6.96 PC {44:6} [M+Na]+
728.5 1.28 × 10−44 9.25 PC {32:3} [M+H]+
832.7 5.16 × 10−47 11.76 PC {40:7} [M+H]+
884.7 6.0448 × 10−47 13.75 PC {42:6} [M+Na]+
Underexpressed in extracellular vesicles of PC9R cell
732.6 9.18 × 10−1 0.99 PC {32:1} [M+H]+
746.5 6.04 × 10−1 0.99 PC {O-34:1} [M+H]+/PC {P-34:0} [M+H]+
782.6 2.58 × 10−1 0.97 PC {34:1} [M+Na]+/PC {36:4} [M+H]+
718.7 3.15 × 10−3 0.93 PC {O-32:1} [M+H]+/PC {P-32:0} [M+H]+
704.6 4.04 × 10−4 0.93 PC {30:1} [M+H]+
820.6 9.04 × 10−3 0.91 PC {40:5} [M+H]+
768.6 4.89 × 10−9 0.88 PC {O-36:4} [M+H]+/PC {P-36:3} [M+H]+
780.6 3.33 × 10−7 0.88 PC {36:5} [M+H]+
760.6 1.08 × 10−6 0.85 PC {34:1} [M+H]+
787.8 9.40 × 10−18 0.82 SM{d40:1}[M+H]+
703.6 1.1716 × 10−18 0.75 SM {d34:1} [M+H]+
725.5 1.70 × 10−19 0.75 SM {d34:1} [M+Na]+
522.3 8.13 × 10−9 0.74 LPC {18:1} [M+H]+
810.6 2.10 × 10−25 0.73 PC {36:1} [M+Na]+/PC {38:4} [M+H]+
675.6 1.42 × 10−26 0.73 SM {d32:1} [M+H]+
774.6 1.12 × 10−27 0.71 PC {34:5} [M+Na]+
812.6 1.14 × 10−22 0.71 PC {38:3} [M+H]+
798.6 1.56 × 10−19 0.71 PC {34:1} [M+K]+
759.7 1.41 × 10−23 0.7 PC {38:1} [M+H]+
794.6 1.42 × 10−18 0.69 PC {O-38:5} [M+H]+/PC {P-38:4} [M+H]+
518.3 6.30 × 10−15 0.68 LPC {18:3} [M+H]+
504.5 1.12 × 10−16 0.62 LPC {14:1} [M+K]+
649.5 2.01 × 10−9 0.55 SM {d30:0} [M+H]+
546.4 1.16 × 10−24 0.55 LPC {20:3} [M+H]+
562.4 5.08 × 10−23 0.54 LPC {18:0} [M+K]+
796.6 1.85 × 10−30 0.53 PC {O-38:4} [M+H]+/PC {P-38:3} [M+H]+
572.6 5.08 × 10−21 0.51 LPC {22:4} [M+H]+
544.3 1.07 × 10−49 0.28 LPC {20:4} [M+H]+
758.6 3.07 × 10−47 0.19 PC {34:2} [M+H]+
808.6 4.13 × 10−54 0.15 PC {38:5} [M+H]+
785.7 3.58 × 10−59 0.08 SM{d40:2}[M+H]+

Peak position was indicated by the m/z ratio. MS peaks were assigned using lipid databases, Lipid Search or LIPID Metabolites and Pathways Strategy (LIPID MAPS) database (www.lipidmaps.org).

a)

p-value <0.01, fold change>1.5.

b)

Ratio, extracellular vesicles of PC9R cell/PC9 cell ratio.

P-, plasmenyl; O-, plasmanyl.

PC, phosphatidylcholines.

P-LPC, lysophosphatidylcholines.

P-SM, sphingomyelines.